• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Oramed Pharmaceuticals Inc. (ORMP)

    -NasdaqCM
    6.54 Down 0.48(6.84%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.02
    Open:6.97
    Bid:6.30 x 1000
    Ask:7.49 x 200
    1y Target Est:30.00
    Beta:0.34
    Next Earnings Date:N/A
    Day's Range:6.26 - 7.00
    52wk Range:3.71 - 14.80
    Volume:553,926
    Avg Vol (3m):207,902
    Market Cap:70.85M
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ORMP

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Aug-15) :-0.92
    Quarterly EPS Est (Feb-15) :-0.22
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback